What is the recommended management for Tetralogy of Fallot (TOF) with absent pulmonary valve?

Management of Tetralogy of Fallot with Absent Pulmonary Valve

Early surgical repair is the definitive management for TOF with absent pulmonary valve, with timing and technique dictated by respiratory symptoms and airway compromise—symptomatic neonates and infants require urgent intervention with aggressive pulmonary artery management and potential airway stabilization procedures, while older asymptomatic patients can undergo elective repair.

Timing of Intervention

The critical decision point is whether the patient is symptomatic from airway compression:

Symptomatic Neonates/Infants (Respiratory Distress)

• Proceed to urgent surgical repair regardless of age 1, 2
• These patients have the highest mortality risk (historically 20-60%, now improved to ~10-25% with modern techniques) 1, 3
• Expect prolonged ventilation (mean 36 days in neonates vs 2.6 days in children ≥1 year) 2
• Bronchial stenosis and age ≤6 months are the main factors influencing postoperative survival 4

Asymptomatic or Mildly Symptomatic Patients

• Delay repair until >6 months of age when feasible 4
• Survival approaches 100% when repair is performed after 6 months vs 40% when ≤6 months 4
• Median age at repair in contemporary series is 51 days, but this reflects symptomatic presentation 1

Surgical Technique

Right Ventricular Outflow Tract Reconstruction

Prioritize pulmonary valve implantation over transannular patch to establish valve competence 1, 2:

• Valved conduit (homograft or bioprosthetic): Most commonly used (64% of cases) 3
• Monocusp valve patch: Preferred over bovine jugular vein (BJV) conduits due to lower restenosis rates and better quality of life 4
• Avoid BJV-valved conduits: Associated with higher RV-PA gradients, increased restenosis risk, and need for reintervention 4
• Transannular patch: Used in 34% but results in severe pulmonary regurgitation requiring later valve replacement 3

Pulmonary Artery Management

Aggressive PA intervention is essential to relieve airway compression 1, 2:

• PA plication or reduction: Performed in approximately 50% of cases 2
• PA replacement with thin-walled Gore-Tex grafts: Superior outcomes with no PA reoperations vs 23% reoperation rate without replacement 1
• PA suspension: May be needed as additional procedure for persistent airway compression 2

Airway Interventions

Consider concomitant airway procedures in symptomatic patients 1, 2:

• Tracheobronchopexy/plasty at initial repair prevents subsequent airway reinterventions 1
• Additional postoperative interventions may include: pulmonary artery suspension (n=4), innominate artery suspension (n=2), or lobectomy (n=2) for persistent airway compromise 2
• Tracheostomy required in ~15% of cases 1

Follow-Up and Reintervention

Expected Outcomes

• In-hospital mortality: 25% 3
• Post-discharge 25-year survival: 92%—similar to simple TOF with non-valve sparing procedures 3
• All deaths occur within first 13 months postoperatively 5

Reintervention Rates

• Freedom from RVOT reoperation: 89% at 5 years, 59% at 10 years 2
• Patients with initial valve implantation: 50% require valve replacement at median 9 months 1
• Patients with initial transannular patch: Only 12.5% require subsequent valve replacement 1

Surveillance Requirements

Follow standard TOF guidelines 6, 7, 6:

• Annual follow-up with ACHD cardiologist (Class I)
• Echocardiography and/or CMR by ACHD-trained staff (Class I)
• Genetic screening for 22q11 deletion (Class I)—present in 35% of cases 5

Prognostic Factors

Predictors of Mortality

• Right ventricular dysfunction: Independently predicts overall mortality (OR 7.9) 5
• Left ventricular dysfunction: Predicts fetal demise (OR 7.4) 5
• Bronchial stenosis: Major factor for postoperative survival 4
• Preoperative mechanical ventilation: Associated with prolonged postoperative ventilation 2
• Mediastinal shift: Reflects airway obstruction and abnormal lung development 5

Factors NOT Predictive

• Pulmonary artery diameter measurements do not correlate with outcomes 5

Common Pitfalls

1. Underestimating airway issues: The combination of aneurysmal PAs causing tracheobronchomalacia is the primary driver of morbidity and mortality—address aggressively at initial repair
2. Using BJV conduits: Associated with worse outcomes; prefer monocusp patches or homografts
3. Delaying surgery in symptomatic infants: Respiratory symptoms mandate urgent intervention despite higher risk
4. Inadequate PA management: Simple repair without PA reduction/replacement leads to persistent airway compression